Skip to main content

Dexamethasone Sodium Phosphate Injection

Last Updated: January 9, 2023
Status: Current

Products Affected - Description
    • Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 10 mL vial, 10 count, NDC 55150-0305-10
    • Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 1 mL vial, 25 count, NDC 55150-0237-01 - discontinued
    • Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 5 mL vial, 25 count, NDC 55150-0238-05 - discontinued
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 30 mL multiple dose vial, 1 count, NDC 63323-0165-30
    • Dexamethasone Sodium Phosphate injection, Hikma, 10 mg/mL, 1 mL vial, 25 count, NDC 00641-0367-25
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 1 mL vial, 25 count, NDC 00641-6145-25
Reason for the Shortage
    • American Regent is not marketing dexamethasone sodium phosphate injection at this time.
    • AuroMedics did not provide a reason for the shortage. They discontinued dexamethasone 4 mg/mL 1 mL and 5 mL vials in early-2022.
    • Fresenius Kabi has dexamethasone sodium phosphate on shortage due to increased demand.
    • Mylan Institutional has dexamethasone injection available.
    • Hikma has dexamethasone injection on shortage due to increased demand.
    • Somerset Therapeutics had 10 mg/mL 1 mL and 10 mL vials on shortage due to increased demand.
Available Products
    • Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 55150-0304-25
    • Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 30 mL vial, 25 count, NDC 55150-0239-30
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0109-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL preservative-free single dose vial, 25 count, NDC 63323-0506-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 63323-0516-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0106-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 63323-0165-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0165-05
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 5 mL vial, 25 count, NDC 00641-6146-25
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0420-10
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 1 mL vial, 25 count, NDC 67457-0423-12
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 30 mL vial, 25 count, NDC 67457-0421-30
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 5 mL vial, 25 count, NDC 67457-0422-54
    • Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 70069-0021-25
    • Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 70069-0025-10

Estimated Resupply Dates

    • Eugia has dexamethasone sodium phosphate 10 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
    • Fresenius Kabi has short-dated dexamethasone sodium phosphate 4 mg/mL 30 mL vials available with an expiration date of < 9 months.
    • Hikma has dexamethasone sodium phosphate 4 mg/mL 1 mL vials on allocation. The 10 mg/mL 1 mL vials are on back order and the company estimates a release date of mid-January 2023.

Updated

Updated January 9, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 18, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.